These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4396706)

  • 41. [Adrenergic therapy and vigilance: beta-2 sympathomimetic aerosols in asthma].
    Moulin M; Hugues FC; Bigot MC; Mosquet B
    Allerg Immunol (Paris); 1988 Oct; 20(8):306, 309, 311. PubMed ID: 2903751
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Granulocyte response in vitro to isoproterenol, histamine, and prostaglandin E1, during treatment with beta-adrenergic aerosols in asthma.
    Busse WW; Bush RK; Cooper W
    Am Rev Respir Dis; 1979 Aug; 120(2):377-84. PubMed ID: 38719
    [No Abstract]   [Full Text] [Related]  

  • 43. Asthma mortality and inhaled beta agonist therapy.
    Morley J
    Aust N Z J Med; 1992 Aug; 22(4):388-9. PubMed ID: 1359864
    [No Abstract]   [Full Text] [Related]  

  • 44. Adrenoceptors and bronchial asthma.
    Jack D
    Scand J Respir Dis Suppl; 1974; 89():29-34. PubMed ID: 4369761
    [No Abstract]   [Full Text] [Related]  

  • 45. Inhaled beta 2-adrenergic agonists in asthma: the evolving dilemma.
    Hui KP
    Singapore Med J; 1994 Jun; 35(3):237-9. PubMed ID: 7997893
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of bronchoconstriction by aerosols of prostaglandins E1 and E2.
    Wasserman MA; Griffin RL; Marsalisi FB
    J Pharmacol Exp Ther; 1980 Jul; 214(1):68-73. PubMed ID: 7391972
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison of the beta-adrenoceptor stimulant properties of salbutamol, orciprenaline and soterenol with those of isoprenaline.
    Farmer JB; Levy GP; Marshall RJ
    J Pharm Pharmacol; 1970 Dec; 22(12):945-7. PubMed ID: 4395522
    [No Abstract]   [Full Text] [Related]  

  • 48. Pharmacological control of asthma.
    Wilson AF; McPhillips JJ
    Annu Rev Pharmacol Toxicol; 1978; 18():541-61. PubMed ID: 25612
    [No Abstract]   [Full Text] [Related]  

  • 49. Anti-allergic properties of beta-adrenoceptor stimulants.
    Sörenby L
    Acta Pharmacol Toxicol (Copenh); 1979; 44 Suppl 2():31-2. PubMed ID: 41397
    [No Abstract]   [Full Text] [Related]  

  • 50. [Physiolopathology of secondary bronchoconstrictor effects caused by repeated use of adrenergics (experimental study)].
    Harichaux P; Hary L; Delucheux F
    Lille Med; 1978 Feb; 23(2):92-5. PubMed ID: 26004
    [No Abstract]   [Full Text] [Related]  

  • 51. Adrenergic agonists and bronchodilator aerosol therapy in asthma.
    Shim C
    Clin Chest Med; 1984 Dec; 5(4):659-68. PubMed ID: 6151440
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of force--frequency relation during AV-block, sinus node block and beta-adrenoceptor block in conscious animals.
    De Pauw M; Vilaine JP; Heyndrickx GR
    Basic Res Cardiol; 2004 Sep; 99(5):360-71. PubMed ID: 15338245
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SElectivity of broncholidlator action of salbutamol in asthmatic patients.
    Paterson JW; Evans RJ; Prime FJ
    Br J Dis Chest; 1971 Jan; 65(1):21-38. PubMed ID: 5110174
    [No Abstract]   [Full Text] [Related]  

  • 54. Metaproterenol.
    Med Lett Drugs Ther; 1974 May; 16(11):45-6. PubMed ID: 4151674
    [No Abstract]   [Full Text] [Related]  

  • 55. [Comparison of the bronchodilating effects of five beta-adrenergic stimulants administered by inhalation to patients with bronchial asthma].
    Kokubu H
    Arerugi; 1993 Jun; 42(6):699-705. PubMed ID: 8102230
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cross tolerance to histamine by the chronic administration of histamine analogues.
    Ambrus JL; Ambrus CM
    Res Commun Chem Pathol Pharmacol; 1972 Mar; 3(2):265-72. PubMed ID: 4679852
    [No Abstract]   [Full Text] [Related]  

  • 57. In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action.
    Battram C; Charlton SJ; Cuenoud B; Dowling MR; Fairhurst RA; Farr D; Fozard JR; Leighton-Davies JR; Lewis CA; McEvoy L; Turner RJ; Trifilieff A
    J Pharmacol Exp Ther; 2006 May; 317(2):762-70. PubMed ID: 16434564
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Observations on the sub-division of beta-adrenoreceptors in the circulation of the dog.
    Ekue JM; Shanks RG; Zaidi SA
    Br J Pharmacol; 1970 May; 39(1):184P-185P. PubMed ID: 4392961
    [No Abstract]   [Full Text] [Related]  

  • 59. Zatebradine inhibits tachycardia induced by bronchodilators without affecting respiratory resistance in dogs.
    Yamazaki K; Furukawa Y; Hirose M; Chiba S
    Eur J Pharmacol; 1997 Feb; 320(1):21-7. PubMed ID: 9049598
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Symposium on isoproterenol therapy in asthma.
    Ann Allergy; 1973 Jan; 31(1):1-44. PubMed ID: 4404961
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.